UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 4)*
OPTION CARE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01
--------------------------------------------------------------------------------
(Title of Class of Securities)
CUSIP NO. 683948 10 3
--------------------------------------------------------------------------------
(CUSIP Number)
John N. Kapoor, Ph.D Copy Thomas J. Murphy
EJ Financial Enterprises, Inc. To: McDermott Will & Emery LLP
225 E. Deerpath, Suite 250 227 West Monroe Street
Lake Forest, IL 60045 Chicago, IL 60606
--------------------------------------------------------------------------------
(847) 295-8665 (312) 372-2000
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications
February 24, 2005
--------------------------------------------------------------------------------
(Date of Event Which Requires
Filing of This Statement)
If the person filing has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
check the following box. |_|
NOTE: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SCHEDULE 13D
CUSIP NO. 683948 10 3 PAGE 2 OF 10 PAGES
--------------------------------------------------------------------------------
(1) Names of Reporting Persons.
S.S. or Identification Nos. of above persons (entities only).
John N. Kapoor, Ph.D
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (See Instructions) (b) /x/
--------------------------------------------------------------------------------
(3) Sec Use Only
--------------------------------------------------------------------------------
(4) Source of Funds (see instructions) PF
--------------------------------------------------------------------------------
(5) Check if disclosure of legal proceedings is required pursuant to
Items 2(d) or 2(e).
--------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
USA
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each (7) Sole Voting Power
Reporting Person with:
933,307
----------------------------------
(8) Shared Voting Power
5,446,061
----------------------------------
(9) Sole Dispositive Power
933,307
----------------------------------
(10) Shared Dispositive Power
5,446,061
--------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
6,379,368
--------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) / /
--------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
29.8%
--------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions)
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13D
CUSIP NO. 683948 10 3 PAGE 3 OF 10 PAGES
--------------------------------------------------------------------------------
(1) Names of Reporting Persons.
S.S. or Identification Nos. of above persons (entities only).
E.J. Financial/ OCI Management L.P.
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (See Instructions) (b) /x/
--------------------------------------------------------------------------------
(3) Sec Use Only
--------------------------------------------------------------------------------
(4) Source of Funds (see instructions) OO
--------------------------------------------------------------------------------
(5) Check if disclosure of legal proceedings is required pursuant to
Items 2(d) or 2(e).
--------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
Delaware
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each (7) Sole Voting Power
Reporting Person with:
5,446,061
----------------------------------
(8) Shared Voting Power
0
----------------------------------
(9) Sole Dispositive Power
5,446,061
----------------------------------
(10) Shared Dispositive Power
0
--------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
5,446,061
--------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) / /
--------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
25.4%
--------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions)
PN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13D
CUSIP NO. 683948 10 3 PAGE 4 OF 10 PAGES
--------------------------------------------------------------------------------
(1) Names of Reporting Persons.
S.S. or Identification Nos. of above persons (entities only).
Pharma Nevada, Inc.
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (See Instructions) (b) /x/
--------------------------------------------------------------------------------
(3) Sec Use Only
--------------------------------------------------------------------------------
(4) Source of Funds (see instructions) OO
--------------------------------------------------------------------------------
(5) Check if disclosure of legal proceedings is required pursuant to
Items 2(d) or 2(e).
--------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
Nevada
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each (7) Sole Voting Power
Reporting Person with:
5,446,061
----------------------------------
(8) Shared Voting Power
0
----------------------------------
(9) Sole Dispositive Power
5,446,061
----------------------------------
(10) Shared Dispositive Power
0
--------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
5,446,061
--------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) / /
--------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
25.4%
--------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions)
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SCHEDULE 13D
CUSIP NO. 683948 10 3 PAGE 5 OF 10 PAGES
--------------------------------------------------------------------------------
(1) Names of Reporting Persons.
S.S. or Identification Nos. of above persons (entities only).
Editha S. Kapoor
--------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (See Instructions) (b) /x/
--------------------------------------------------------------------------------
(3) Sec Use Only
--------------------------------------------------------------------------------
(4) Source of Funds (see instructions) PF
--------------------------------------------------------------------------------
(5) Check if disclosure of legal proceedings is required pursuant to
Items 2(d) or 2(e).
--------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
USA
--------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each (7) Sole Voting Power
Reporting Person with:
0
----------------------------------
(8) Shared Voting Power
5,446,061
----------------------------------
(9) Sole Dispositive Power
0
----------------------------------
(10) Shared Dispositive Power
5,446,061
--------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
5,446,061
--------------------------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) / /
--------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
25.4%
--------------------------------------------------------------------------------
(14) Type of Reporting Person (See Instructions)
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
This Amendment No. 4 (the "Amendment") to Schedule 13D is
being filed to disclose that on February 24, 2005 E.J. Financial/OCI Management,
L.P., a Delaware limited partnership ("EJ/OCI Management"), sold 860,000 shares
of common stock, par value $0.01 (the "Shares") of Option Care, Inc. (the
"Company" or "Issuer") in an privately negotiated transaction.
ITEM 2. IDENTITY AND BACKGROUND
(a) - (c), (f) This Amendment is filed jointly by John N. Kapoor, Ph.D, a United
States citizen ("Dr. Kapoor"), EJ/OCI Management, a Delaware limited
partnership, Pharma Nevada, Inc., a Nevada corporation ("PNI"), and Editha S.
Kapoor, a United States Citizen ("Mrs. Kapoor") (collectively, the "Reporting
Persons," or individually the "Reporting Person"). The address of each of the
Reporting Persons is 225 East Deerpath Road, Suite 250, Lake Forest, Illinois
60045. Dr. Kapoor's principal occupation is management of various portfolio
holdings as president of EJ Financial Enterprises, Inc. Mrs. Kapoor's principal
occupation is management of various portfolio holdings.
(d) - (e) During the last five years, none of the Reporting Persons has been (i)
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Dr. Kapoor and Mrs. Kapoor are husband and wife and are the sole directors
and the president and vice president, respectively, of PNI. PNI is the general
partner of EJ/OCI Management. Dr. Kapoor is the sole trustee and sole
beneficiary of the John N. Kapoor Trust dated 9/20/89 (the "Trust") and the
general partner of the Kapoor Family Partnership, L.P., a Delaware limited
partnership (the "Family Partnership").
Dr. Kapoor may be deemed to beneficially own 6,379,368 Shares,
representing approximately 29.8% of the outstanding Shares, due to the
following: (i) 5,446,061 Shares held by EJ/OCI Management; (ii) 298,386 Shares
held by the Trust; and (iii) 634, 921 Shares held by the Family Partnership.
PNI may be deemed to own beneficially 5,446,061 Shares held by
EJ/OCI Management, representing approximately 25.4% of the outstanding Shares.
Mrs. Kapoor may be deemed to beneficially own 5,446,061 Shares
through EJ/OCI Management, representing approximately 25.4% of the outstanding
Shares.
EJ/OCI Management and PNI each disclaim ownership of the
Shares beneficially owned by Dr. Kapoor, Mrs. Kapoor, the Trust and the Family
Limited Partnership. Mrs. Kapoor disclaims ownership of the Shares beneficially
owned by Dr. Kapoor, the Trust and the Family Partnership. The Trust disclaims
ownership of the Shares beneficially owned by Dr. Kapoor, Mrs. Kapoor, EJ/OCI
Management, PNI and the Family Partnership. The Family Partnership disclaims
ownership of Shares beneficially owned by Dr. Kapoor, Mrs. Kapoor, EJ/OCI
Management, PNI and the Trust.
(b) Dr. Kapoor has sole voting and dispositive power over 933,307 Shares
(comprised of Shares held by the Trust and the Family Partnership) and shared
voting and dispositive power over 5,446,061 Shares (comprised of shares held by
the EJ/OCI Management). PNI has sole voting and dispositive power over 5,446,061
Shares (comprised of shares held by EJ/OCI Management). Mrs. Kapoor has shared
voting and dispositive power over 5,446,061 Shares (comprised of shares held by
EJ/OCI Management).
(c) There were no transactions effected by the Reporting Persons during the past
sixty days in the class of securities reported hereunder.
(d) Not Applicable
(e) Not Applicable
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
The following Exhibits are filed with this Amendment:
A. Agreement to Jointly File Schedule 13D
--------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 28, 2005 /s/ John N. Kapoor
-----------------------------------
John N. Kapoor
February 28, 2005 E.J. Financial/ OCI Management L.P.
By: Pharma Nevada, Inc., its
General Partner
/s/ John N. Kapoor
-----------------------------------
John N. Kapoor, Ph.D, President
February 28, 2005 Pharma Nevada, Inc.
/s/ John N. Kapoor
-----------------------------------
John N. Kapoor, Ph.D, President
February 28, 2005
/s/ Editha S. Kapoor
-----------------------------------
Editha S. Kapoor
EXHIBIT A
AGREEMENT
TO
JOINTLY FILE SCHEDULE 13D
The undersigned hereby agree to jointly prepare and file with
regulatory authorities this Schedule 13D and any future amendment thereto
reporting each of the undersigned's ownership of securities of NeoPharm, Inc.,
and hereby affirm that such Schedule 13D is being filed on behalf of each of the
undersigned.
February 28, 2005
/s/ John N. Kapoor
-----------------------------------
John N. Kapoor
February 28, 2005 E.J. Financial/ OCI Management L.P.
By: Pharma Nevada, Inc., its
General Partner
/s/ John N. Kapoor
-----------------------------------
John N. Kapoor, Ph.D, President
February 28, 2005 Pharma Nevada, Inc.
/s/ John N. Kapoor
-----------------------------------
John N. Kapoor, Ph.D, President
February 28, 2005
/s/ Editha S. Kapoor
-----------------------------------
Editha S. Kapoor